# OncoVision: METABRIC Risk Stratifier ğŸ§¬

![Python](https://img.shields.io/badge/Python-3.11%2B-blue)
![Streamlit](https://img.shields.io/badge/Streamlit-1.49.1-FF4B4B)
![Scikit-Survival](https://img.shields.io/badge/Scikit--Survival-0.22.0-orange)
![License](https://img.shields.io/badge/License-MIT-green)

An AI-powered clinical decision support system for breast cancer survival prediction, built on the METABRIC dataset using advanced machine learning techniques.

![OncoVision Dashboard](https://via.placeholder.com/800x400.png?text=OncoVision+Dashboard+Screenshot)
*Example: Replace with actual dashboard screenshot*

## ğŸ“Š Key Results & Performance

### Model Performance Comparison
![Model Performance](https://via.placeholder.com/600x300.png?text=Model+Performance+Comparison+Chart)
*C-index scores across different algorithms*

| Model | C-Index | Training Time |
|-------|---------|---------------|
| Random Survival Forest | **0.7045** | 6.24s |
| Gradient Boosting Survival | 0.6913 | 3.68s |
| CoxNet (ElasticNet) | 0.6839 | 0.04s |
| CoxPH | 0.6827 | 0.80s |

### Feature Importance Analysis
![Feature Importance](https://via.placeholder.com/600x400.png?text=Feature+Importance+Plot)
*Top predictive features from Random Survival Forest*

1. **Age at Diagnosis** (0.0334) - Primary risk factor
2. **Nottingham Prognostic Index** (0.0327) - Validated clinical tool
3. **Lymph Nodes Examined Positive** (0.0205) - Critical prognostic indicator
4. **Type of Breast Surgery** (0.0118) - Treatment approach
5. **PAM50 + Claudin-low Subtype** (0.0091) - Molecular classification

### Risk Stratification Results
![Risk Stratification](https://via.placeholder.com/700x400.png?text=Kaplan-Meier+Risk+Stratification)
*Clear separation of survival curves by risk group*

| Risk Group | Patients | Event Rate | Median Survival |
|------------|----------|------------|-----------------|
| **Low Risk** | 167 | 35.9% | 143.0 months |
| **Medium Risk** | 167 | 74.3% | 97.9 months |
| **High Risk** | 168 | 87.5% | 96.6 months |
```

## ğŸš€ Quick Start

### Installation

```bash
# Clone the repository
git clone https://github.com/yourusername/OncoVision-METABRIC-Risk-Stratifier.git
cd OncoVision-METABRIC-Risk-Stratifier

# Create virtual environment
python -m venv oncoenv
source oncoenv/bin/activate  # Linux/Mac
# oncoenv\Scripts\activate  # Windows

# Install dependencies
pip install -r requirements.txt
```

### Usage

```bash
# Run the Streamlit application
streamlit run streamlit_app.py

# Access the web interface at http://localhost:8501
```

### Data Processing Pipeline
![Data Processing Pipeline](https://via.placeholder.com/800x200.png?text=Data+Processing+Pipeline)
*From raw data to actionable insights*

## ğŸ—ï¸ Architecture

```
OncoVision/
â”œâ”€â”€ data/
â”‚   â”œâ”€â”€ metabric_processed_clean.csv      # Cleaned dataset
â”‚   â””â”€â”€ feature_importances.csv           # Feature importance scores
â”œâ”€â”€ models/
â”‚   â”œâ”€â”€ best_model_random_forest.pkl      # Trained model
â”‚   â””â”€â”€ label_encoders.pkl                # Preprocessing encoders
â”œâ”€â”€ notebooks/
â”‚   â”œâ”€â”€ 01_data_preprocessing.ipynb       # Data cleaning & EDA
â”‚   â”œâ”€â”€ 02_model_training.ipynb           # Model development
â”‚   â””â”€â”€ 03_results_analysis.ipynb         # Performance evaluation
â”œâ”€â”€ streamlit_app.py                      # Main application
â”œâ”€â”€ requirements.txt                      # Dependencies
â””â”€â”€ README.md                             # This file
```

## ğŸ”¬ Methodology

### Data Source
- **METABRIC Dataset**: 2,509 breast cancer patients with 34 clinical features
- **Target Variables**: Overall survival status and duration
- **Validation**: Stratified train-test split (80-20)

### Machine Learning Approach
- **Algorithm**: Random Survival Forest (best performer)
- **Evaluation**: Concordance Index (C-index)
- **Validation**: 5-fold cross-validation
- **Interpretation**: Permutation importance analysis

### Preprocessing
<img width="1389" height="790" alt="image" src="https://github.com/user-attachments/assets/18d1b302-2d49-492b-81c2-f1a4b3bb8c68" />

*Initial missing data patterns before imputation*

```python
# Advanced clinical imputation strategy
df['Feature'] = df.groupby('Cancer_Type')['Feature'].transform(
    lambda x: x.fillna(x.mode()[0] if not x.mode().empty else fallback_value)
)
```

## ğŸ“ˆ Results Interpretation

### Clinical Validation
<img width="1389" height="989" alt="image" src="https://github.com/user-attachments/assets/b875efbf-40e2-4e9e-9bbe-6933812505dd" />
*Alignment with established clinical knowledge*

The model successfully recapitulates known prognostic factors:
- âœ… Nottingham Prognostic Index (validated clinical tool)
- âœ… Lymph node status (TNM staging component)  
- âœ… Age at diagnosis (established risk factor)
- âœ… Tumor size (TNM staging component)
- âœ… ER/HER2 status (treatment decision drivers)

### Model Insights
<img width="1189" height="790" alt="image" src="https://github.com/user-attachments/assets/c2394c96-9c44-4b5d-b18f-bdda65b4a63f" />

**High-Risk Group Identification**: The model successfully identified 168 patients with 87.5% event rate, representing those who may benefit from aggressive intervention


## ğŸ¯ Clinical Applications

### Risk-Based Stratification
<img width="1490" height="1189" alt="image" src="https://github.com/user-attachments/assets/bf2350e3-b7c7-4976-b63f-5a3eb0cfa891" />
- **Low Risk**: Consider therapy de-escalation
- **Medium Risk**: Standard guideline-concordant care  
- **High Risk**: Aggressive multimodal therapy

### Decision Support
- Treatment planning and personalization
- Resource allocation prioritization
- Clinical trial enrollment guidance
- Patient counseling and education

## ğŸ“‹ Example Usage

![Example Prediction](https://via.placeholder.com/700x500.png?text=Example+Risk+Prediction)
*Sample patient assessment with risk score*

```python
# Example risk prediction
patient_data = {
    'Age_at_Diagnosis': 58.5,
    'Nottingham_index': 4.2, 
    'Lymph_Nodes': 3,
    'Tumor_Size': 28.0,
    'Tumor_Stage': 2
}

risk_score = model.predict(patient_data)  # Returns: 0.723 (High Risk)
```

## ğŸ”® Future Enhancements

- [ ] Integration with electronic health records
- [ ] Real-time API for clinical systems
- [ ] Additional validation on external datasets
- [ ] Explainable AI features for clinical interpretability
- [ ] Mobile application for point-of-care use

## ğŸ“š References

1. Curtis, C., et al. (2012). The genomic and transcriptomic architecture of 2,000 breast tumours. *Nature*, 486(7403), 346-352.
2. Ishwaran, H., et al. (2008). Random survival forests. *The Annals of Applied Statistics*, 2(3), 841-860.
3. scikit-survival documentation. https://scikit-survival.readthedocs.io/


## ğŸ“„ License

This project is licensed under the MIT License - see the [LICENSE.md](LICENSE.md) file for details.

## âš ï¸ Disclaimer

This tool is for **research and educational purposes only**. It does not replace clinical judgment. Always consult with qualified healthcare professionals for medical decisions.
